Global Custom Market Research Reports Provider Company

phone

Avillion LLP - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Published Date: 11 Apr 2018
  • Number of Pages: 19
  • Category: Pharmaceuticals
  • Country: United Kingdom
Summary

Avillion LLP (Avillion) is a provider of drug development services. The company supports pharmaceutical and biotechnology companies, with focus on clinical development and approval of late stage pharmaceutical products and candidates. It maintains a business model for the clinical development and regulatory approval of late stage pharmaceutical products. Avillions BOSULIF serves as a first line treatment for patients suffering with chronic phase Philadelphia chromosome positive chronic myelogenous leukemia. The company incurs full clinical and regulatory risk. It also provides global clinical trial, global regulatory, CRO management services and finance models for the financial pressures on the market. The company operates through other pharmaceutical and biotechnology companies in different parts of the world. Avillion is headquartered in London, the UK.

Avillion LLP - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons To Buy


Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Publisher Name : GlobalData

3
List of Tables 4
List of Figures 4
Avillion LLP, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Avillion LLP, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Avillion LLP, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Avillion LLP, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Avillion LLP, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Avillion LLP, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Avillion Secures Funds from Royalty Pharma 10
Avillion Raises Funds Through Venture Financing 11
Partnerships 12
Avillion Enters into Co-Development Agreement with Pearl Therapeutics 12
Avillion Enters into Co-Development Agreement with Merck 13
Avillion LLP - Key Competitors 14
Avillion LLP - Key Employees 15
Avillion LLP - Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Corporate Communications 17
Oct 03, 2017: Avillion Appoints Kathryn J. Gregory as Chief Business Officer 17
Jan 20, 2017: Avillion Strengthens Clinical and Regulatory Development Capabilities with the Appointment of Mark Weinberg as Chief Medical Officer 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List Of Tables

List of Tables
Avillion LLP, Pharmaceuticals & Healthcare, Key Facts 2
Avillion LLP, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Avillion LLP, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Avillion LLP, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Avillion LLP, Deals By Therapy Area, 2012 to YTD 2018 8
Avillion LLP, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Avillion Secures Funds from Royalty Pharma 10
Avillion Raises Funds Through Venture Financing 11
Avillion Enters into Co-Development Agreement with Pearl Therapeutics 12
Avillion Enters into Co-Development Agreement with Merck 13
Avillion LLP, Key Competitors 14
Avillion LLP, Key Employees 15

List Of Figures

List of Figures
Avillion LLP, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Avillion LLP, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Avillion LLP, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Avillion LLP, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Avillion LLP, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Avillion LLP, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Avillion LLP, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Avillion LLP, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Avillion LLP (Avillion) is a provider of drug development services. The company supports pharmaceutical and biotechnology companies, with focus on clinical development and approval of late stage pharmaceutical products and

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports